Trial Profile
Symptomatic Treatment of Vascular Cognitive Impairment
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs Galantamine (Primary) ; Methylphenidate
- Indications Vascular dementia
- Focus Therapeutic Use
- Acronyms STREAM-VCI
- 24 Jun 2014 New trial record